Skip to Main Content

An official website of the United States government

Here you can browse the complete list of projects for PLCO whose requests for data/biospecimens were approved.

Name Principal Investigator Institution Study Date Approved Project ID
Prostate dataset evaluation Timothy Wong Independent PLCO Oct 5, 2017 PLCO-316
A nested case-control study of serum levels of polyfluoroalkyl chemicals (PFCs) and renal cell carcinoma among participants in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial Jonathan Hofmann National Cancer Institute PLCO Sep 28, 2017 2017-0027
Publicly available prostate cancer datasets Tim Hulsen Philips Research PLCO Sep 27, 2017 PLCO-309
Methodologic research for stochastic models of colorectal cancer in natural history and under screening Hormuzd Katki NCI PLCO Sep 27, 2017 PLCO-308
Identifying lethal lung cancers from non-lethal disease using CT and pathology image markers Peng Huang Johns Hopkins University PLCO Sep 20, 2017 2017-9001
Use of head and neck cancer dataset Monika Khurana Independent PLCO Sep 20, 2017 PLCO-306
Chest X-Ray Analysis Using Deep Convolutional Network Ashraf Khalid Semion Inc. PLCO Sep 8, 2017 PLCO-302
Studying neighborhood socioeconomic deprivation and colorectal cancer risk in PLCO Qian Xiao University of Iowa PLCO Sep 7, 2017 PLCO-303
Selecting the risk cut off for the LLP model. Kevin ten Haaf Erasmus MC PLCO Sep 6, 2017 PLCO-301
Detection and classification of abnormalities in Chest X-Rays Robert Rowley Flow Health, Inc. PLCO Sep 5, 2017 PLCO-296
A systematic evaluation of the relationship between reproductive factors and gynecologic outcomes in women from the PLCO: endometriosis, uterine fibroids, and endometrial and ovarian cancer. Ayush Giri Vanderbilt University Medical Center PLCO Sep 5, 2017 PLCO-299
Lifecourse body mass index trajectories and the development of endometrial and ovarian cancers Kara Michels Metabolic Epidemiology Branch PLCO Sep 5, 2017 PLCO-305
Alcohol intake and the risk of colorectal adenomas and colorectal cancer in the PLCO Cancer Screening Trial Kathryn Barry University of Maryland, Baltimore PLCO Sep 5, 2017 PLCO-304
MRI screening for lung cancer: Markov modeling using the NLST CT outcomes data Bradley Allen Northwestern University PLCO Aug 29, 2017 PLCO-300
Expanded Genome-wide Association Study of Lymphoid Malignancies and Related Disorders Sonja Berndt National Cancer Institute PLCO Aug 24, 2017 PLCO-298
The Impact of Medical Guidelines for PSA Testing on Prostate Cancer Treatment Armando Meier University of Basel PLCO Aug 16, 2017 PLCO-294
Change in smoking behaviors and BMI and their impact on the incidence and mortality of lung and colorectal cancer in the PLCO population Ji-Bin Li Sun Yat-sen University Cancer Center PLCO Aug 9, 2017 PLCO-295
Predictive methods for cancer based on machine learning Ashwini Suriyaprakash Independent PLCO Aug 8, 2017 PLCO-292
Serum levels of perfluorinated chemicals (PFCs) and aggressive prostate cancer risk in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial Mark Purdue NCI, DCEG PLCO Aug 3, 2017 2017-0031
Phase 3 validation of a serum miRNA neural network for early detection of ovarian cancer Kevin Elias Brigham and Women's Hospital PLCO Aug 3, 2017 2017-0023